Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexicon Pharmaceuticals (LXRX) FCF Margin (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed FCF Margin for 4 consecutive years, with 43.45% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 153361.0% to 43.45% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2004.46% through Dec 2025, up 168700.0% year-over-year, with the annual reading at 1460.1% for FY2025, 153625.0% up from the prior year.
  • FCF Margin for Q4 2025 was 43.45% at Lexicon Pharmaceuticals, up from 168.05% in the prior quarter.
  • The five-year high for FCF Margin was 58.87% in Q2 2025, with the low at 3081.49% in Q3 2024.